Ikarian Capital »

Celldex Therapeutics shares owned by Ikarian Capital

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $7.9k 200 39.66
2023-09-30 $2.7M 971 2752.00
2023-03-31 $7.8M 216k 35.98
2022-12-31 $12M 268k 44.57
2022-09-30 $8.9M 318k 28.11
2022-06-30 $45M 1.7M 26.96
2022-03-31 $50M 1.5M 34.06
2021-12-31 $57M 1.5M 38.64
2021-09-30 $85M 1.6M 53.99
2021-06-30 $33M 982k 33.44
2021-03-31 $23M 1.1M 20.60
2020-12-31 $31M 1.8M 17.52
2020-09-30 $23M 1.5M 14.83
2020-06-30 $25M 1.9M 13.00